German guidelines on community-acquired acute bacterial meningitis in adults

Publikation: Beitrag in FachzeitschriftÜbersichtsartikel (Review)BeigetragenBegutachtung

Beitragende

  • Matthias Klein - , Klinikum der Ludwig-Maximilians-Universität (LMU) München (Autor:in)
  • Carsten Abdel-Hadi - , Rot­kreuz­kli­ni­kum Mün­chen gGmbH (Autor:in)
  • Robert Bühler - , Bürgerspital Solothurn (Autor:in)
  • Beatrice Grabein - , Klinikum der Ludwig-Maximilians-Universität (LMU) München (Autor:in)
  • Jennifer Linn - , Institut und Poliklinik für Diagnostische und Interventionelle Neuroradiologie (Autor:in)
  • Roland Nau - , Third Institute of Physics, Faculty of Physics, Georg-August University (Autor:in)
  • Bernd Salzberger - , Universitätsklinikum Regensburg (Autor:in)
  • Dirk Schlüter - , Medizinische Hochschule Hannover (MHH) (Autor:in)
  • Konrad Schwager - , Klinik für Hals-Nasen-Ohrenkrankheiten (Autor:in)
  • Hayrettin Tumani - , Universitätsklinikum Ulm (Autor:in)
  • Jörg Weber - , Klinikum Klagenfurt am Wörthersee (Autor:in)
  • Hans-Walter Pfister - , Klinikum der Ludwig-Maximilians-Universität (LMU) München (Autor:in)

Abstract

INTRODUCTION: The incidence of community-acquired acute bacterial meningitis has decreased during the last decades. However, outcome remains poor with a significant proportion of patients not surviving and up to 50% of survivors suffering from long-term sequelae. These guidelines were developed by the Deutsche Gesellschaft für Neurologie (DGN) under guidance of the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) to guide physicians through diagnostics and treatment of adult patients with acute bacterial meningitis.

RECOMMENDATIONS: The most important recommendations are: (i) In patients with suspected acute bacterial meningitis, we recommend that lumbar cerebrospinal fluid (with simultaneous collection of serum to determine the cerebrospinal fluid-serum glucose index and blood cultures) is obtained immediately after the clinical examination (in the absence of severely impaired consciousness, focal neurological deficits, and/or new epileptic seizures). (ii) Next, we recommend application of dexamethasone and empiric antibiotics intravenously. (iii) The recommended initial empiric antibiotic regimen consists of ampicillin and a group 3a cephalosporin (e.g., ceftriaxone). (iv) In patients with severely impaired consciousness, new onset focal neurological deficits (e.g. hemiparesis) and/or patients with newly occurring epileptic seizures, we recommend that dexamethasone and antibiotics are started immediately after the collection of blood; we further recommend that -if the imaging findings do not indicate otherwise -a lumbar CSF sample is taken directly after imaging. (v) Due to the frequent occurrence of intracranial and systemic complications, we suggest that patients with acute bacterial meningitis are treated at an intensive care unit in the initial phase of the disease. In the case of impaired consciousness, we suggest that this is done at an intensive care unit with experience in the treatment of patients with severe CNS diseases.

CONCLUSIONS: The German S2k-guidelines give up to date recommendations for workup, diagnostics and treatment in adult patients with acute bacterial meningitis.

Details

OriginalspracheEnglisch
Aufsatznummer44
FachzeitschriftNeurological research and practice
Jahrgang5
Ausgabenummer1
PublikationsstatusVeröffentlicht - 31 Aug. 2023
Peer-Review-StatusJa

Externe IDs

PubMedCentral PMC10470134
Scopus 85169822659

Schlagworte